Article info

Download PDFPDF

Original article
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study

Authors

  1. Correspondence to Professor Frank Buttgereit; frank.buttgereit{at}charite.de
View Full Text

Citation

Buttgereit F, Strand V, Lee EB, et al
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study

Publication history

  • Received December 21, 2018
  • Revision received February 27, 2019
  • Accepted March 21, 2019
  • First published April 16, 2019.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.